Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A randomized controlled clinical trial to compare the short and long outcomes of Neoadjuvant
chemotherapy with postoperative chemotherapy in patients with resectable locally advanced
colon cancer
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University